Cargando…

Neonatal azithromycin administration for prevention of infant mortality

BACKGROUND. Biannual mass azithromycin administration reduces all-cause childhood mortality in some sub-Saharan African settings, with the largest effects in children aged 1-5 months. Azithromycin has not been distributed to children <1 month due to risk of infantile hypertrophic pyloric stenosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oldenburg, Catherine E., Sié, Ali, Bountogo, Mamadou, Zakane, Alphonse, Compaoré, Guillaume, Ouedraogo, Thierry, Koueta, Fla, Lebas, Elodie, Brogdon, Jessica, Nyatigo, Fanice, Doan, Thuy, Porco, Travis C., Arnold, Benjamin F., Lietman, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NEJM Group, a division of the Massachusetts Medical Society 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172759/ https://www.ncbi.nlm.nih.gov/pubmed/35692260 http://dx.doi.org/10.1056/EVIDoa2100054

Ejemplares similares

Effect of Neonatal Azithromycin on All-Cause and Cause-Specific Infant Mortality: A Randomized Controlled Trial
por: Sié, Ali, et al.
Publicado: (2022)

Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial
por: Sie, Ali, et al.
Publicado: (2023)

Infant mortality and growth failure after oral azithromycin among low birthweight and underweight neonates: A subgroup analysis of a randomized controlled trial
por: Bountogo, Mamadou, et al.
Publicado: (2023)

Antenatal care attendance and risk of low birthweight in Burkina Faso: a cross-sectional study
por: Bountogo, Mamadou, et al.
Publicado: (2021)

Influence of maternal age on birth and infant outcomes at 6 months: a cohort study with quantitative bias analysis
por: Gebreegziabher, Elisabeth, et al.
Publicado: (2023)

Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial
por: Sié, Ali, et al.
Publicado: (2021)

Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial
por: Brogdon, Jessica, et al.
Publicado: (2022)

Indication for Antibiotic Prescription Among Children Attending Primary Healthcare Services in Rural Burkina Faso
por: Sié, Ali, et al.
Publicado: (2021)

Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial
por: Coulibaly, Boubacar, et al.
Publicado: (2022)

A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol
por: Sié, Ali, et al.
Publicado: (2019)

Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial
por: Coulibaly, Boubacar, et al.
Publicado: (2021)

Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial
por: Sie, Ali, et al.
Publicado: (2019)

Adverse Events and Clinic Visits following a Single Dose of Oral Azithromycin among Preschool Children: A Randomized Placebo-Controlled Trial
por: Sié, Ali, et al.
Publicado: (2021)

Distance to primary care facilities and healthcare utilization for preschool children in rural northwestern Burkina Faso: results from a surveillance cohort
por: Oldenburg, Catherine E., et al.
Publicado: (2021)

Access to Improved Sanitation and Nutritional Status among Preschool Children in Nouna District, Burkina Faso
por: Bountogo, Mamadou, et al.
Publicado: (2021)

Anthropometric Differences in Community- Versus Clinic-Recruited Infants Participating in a Trial of Azithromycin for Prevention of Childhood Mortality in Burkina Faso
por: Ouattara, Mamadou, et al.
Publicado: (2023)

Insecticide-treated bed net access and use among preschool children in Nouna District, Burkina Faso
por: Sié, Ali, et al.
Publicado: (2020)

How does baseline anthropometry affect anthropometric outcomes in children receiving treatment for severe acute malnutrition? A secondary analysis of a randomized controlled trial
por: Dah, Clarisse, et al.
Publicado: (2022)

Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
por: Hu, Huiyu, et al.
Publicado: (2022)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Epidemiology of Underweight among Infants in Rural Burkina Faso
por: Sié, Ali, et al.
Publicado: (2022)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Indirect Effect of Azithromycin Use on the Intestinal Microbiome Diversity of Untreated Children: A Randomized Trial
por: Oldenburg, Catherine E, et al.
Publicado: (2019)

The Association between Malnutrition and Malaria Infection in Children under 5 Years in Burkina Faso: A Longitudinal Study
por: Gebreegziabher, Elisabeth, et al.
Publicado: (2023)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions
por: Porco, Travis C., et al.
Publicado: (2020)

Deep sequencing analysis of acute conjunctivitis in Burkina Faso, Africa
por: Bountogo, Mamadou, et al.
Publicado: (2022)

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial
por: Arzika, Ahmed M, et al.
Publicado: (2021)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

Azithromycin for uncomplicated severe acute malnutrition: study protocol for a pilot randomized controlled trial
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Reduction of Coronavirus Burden With Mass Azithromycin Distribution
por: Doan, Thuy, et al.
Publicado: (2020)

Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial
por: Arzika, Ahmed M., et al.
Publicado: (2021)

Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2018)

Indirect effect of oral azithromycin on the gut resistome of untreated children: a randomized controlled trial
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eg0n6mqa7ru0gn73rs3u1518jv